PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · IEX Real-Time Price · USD
33.10
-0.94 (-2.75%)
At close: May 17, 2024, 4:00 PM
39.00
+5.91 (17.84%)
Pre-market: May 20, 2024, 8:59 AM EDT
PTC Therapeutics Employees
PTC Therapeutics had 995 employees on December 31, 2023. The number of employees decreased by 415 or -29.43% compared to the previous year.
Employees
995
Change (1Y)
-415
Growth (1Y)
-29.43%
Revenue / Employee
$932,219
Profits / Employee
-$582,132
Market Cap
2.54B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 995 | -415 | -29.43% |
Dec 31, 2022 | 1,410 | 233 | 19.80% |
Dec 31, 2021 | 1,177 | 210 | 21.72% |
Dec 31, 2020 | 967 | 206 | 27.07% |
Dec 31, 2019 | 761 | 244 | 47.20% |
Dec 31, 2018 | 517 | 144 | 38.61% |
Dec 31, 2017 | 373 | 69 | 22.70% |
Dec 31, 2016 | 304 | -16 | -5.00% |
Dec 31, 2015 | 320 | 127 | 65.80% |
Dec 31, 2014 | 193 | 56 | 40.88% |
Dec 31, 2013 | 137 | 16 | 13.22% |
Dec 31, 2012 | 121 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Bausch Health Companies | 20,270 |
ICU Medical | 14,000 |
Certara | 1,391 |
Inari Medical | 1,300 |
Intellia Therapeutics | 526 |
Immunocore Holdings | 497 |
TG Therapeutics | 264 |
Merus | 229 |
PTCT News
- 2 hours ago - PTC Therapeutics Announces European Commission Returns Translarna™ Opinion to CHMP For Re-evaluation - PRNewsWire
- 6 days ago - PTC Therapeutics Announces FDA Acceptance and Priority Review of the BLA for Upstaza™ - PRNewsWire
- 18 days ago - PTC Therapeutics to Participate at Upcoming Investor Conferences - PRNewsWire
- 24 days ago - PTC Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results - PRNewsWire
- 26 days ago - PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PRNewsWire
- 5 weeks ago - PTC Therapeutics to Host Conference Call to Discuss First Quarter 2024 Financial Results - PRNewsWire
- 7 weeks ago - PTC Announces Submission of Sepiapterin MAA for Treatment of PKU to EMA - PRNewsWire
- 7 weeks ago - PTC Therapeutics, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details- PTCT - Accesswire